Operating Lease, Liability of Oncternal Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Oncternal Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
Oncternal Therapeutics, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2024 was $191,000, a 44% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Oncternal Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$191,000	-$151,000	-44%	30 Sep 2024	10-Q	06 Nov 2024	2024	Q3
Q2 2024	$235,000	-$131,000	-36%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$278,000			31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$318,000			31 Dec 2023	10-K	07 Mar 2024	2023	FY
Q3 2023	$342,000	+$220,000	+180%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$366,000	+$209,000	+133%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q3 2022	$122,000			30 Sep 2022	10-Q	03 Nov 2022	2022	Q3
Q2 2022	$157,000			30 Jun 2022	10-Q	09 Aug 2022	2022	Q2
Q1 2021	$204,000	+$50,000	+32%	31 Mar 2021	10-Q	06 May 2021	2021	Q1
Q1 2020	$154,000			31 Mar 2020	10-Q	07 May 2020	2020	Q1
Q4 2019	$190,000			31 Dec 2019	10-K	16 Mar 2020	2019	FY
Q3 2019	$225,000			30 Sep 2019	10-Q	08 Nov 2019	2019	Q3
Q2 2019	$265,000			30 Jun 2019	10-Q	09 Aug 2019	2019	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.